National Strategy for Combating Antibiotic Resistant Bacteria aptly providing a directive for judicious use of antibiotics in both clinical and veterinary/agricultural settings, development of alternatives to existing antibiotics that would be equally effective and new diagnostic tests that would rapidly detect and track AR bacteria (PCAST, 2014) . In addition, the FDA instated the Veterinary Feed Directive that does not permit use of antibiotics in livestock for purpose of growth promotion in the United States that went into full implementation in 2017 (FDA, 2015) .
Shiga toxin-producing Escherichia coli are foodborne, human pathogens that occur as commensals in the gastrointestinal tract (GIT) of food animals such as cattle, sheep and pigs, where they are subject to the same antibiotic resistance selection as the other microbes in the gut or environment (Brooks et al., 2005; Losada et al., 2016) . STEC cause severe disease in humans ranging from watery to bloody diarrhoea with often-fatal (15%-20% of cases) secondary sequelae (Davis, Kar, & Tarr, 2014) . In the light of the limited therapies available to treat human STEC infections, antibiotics that can eliminate the bacteria without exacerbating the clinical symptoms could provide the much-needed treatment options during early stages of the disease (Knobloch, Hauswaldt, Solbach, Nitschke, & Sayk, 2013; Kurioka, Yunou, Harada, & Kita, 1999; McGannon, Fuller, & Weiss, 2010; Panos, Betsi, & Falagas, 2006; Tajiri et al., 2015) . However, AR in STEC will have to be closely examined prior to making such therapy choices. In this context, here we provide a review of (a) studies reporting AR-STEC in humans, animals and retail food sources (Table 1) , (b) major mechanisms contributing to AR in STEC and (c) a description of pre-harvest control strategies that are being explored to minimize STEC entry into the food chain in order to reduce human infections, which may influence therapeutic and prophylactic choices made in the management of STEC infection and prevalence.
| S TEC INFEC TI ON S AND ANTIB I OTIC THER APY
Escherichia coli O157:H7 is the most prevalent of the STEC serotypes and the first to be associated with bloody diarrhoea, haemorrhagic colitis (HC) and the haemolytic uraemic syndrome (HUS, kidney failure) in humans (Davis et al., 2014; Riley et al., 1983) . Annually, STEC cause more than 265,000 illnesses in the United States Scallan, Griffin, Angulo, Tauxe, & Hoekstra, 2011 ) and 2.8 million acute illnesses around the world (Majowicz et al., 2014) .
E. coli O157 (O157) causes about 36% of the total STEC infections in humans (Lathrop, 2009; Scallan et al., 2011) . Among the non-O157 STEC serogroups, the "Big Six" STEC serogroups (O26, O45, O103, O111, O121 and O145) cause 71% of STEC infections (Brooks et al., 2005) . The U.S. Department of Agriculture-Food Safety and Inspection Service (USDA-FSIS) have designated these "Big Six" STEC serotypes, along with O157, as food adulterants (Brooks et al., 2005; USDA, 2012) . Estimated annual costs of STEC infections range from $26 to $211,084 per patient in the United States, depending on the severity of the disease Buzby & Roberts, 2009; Hoffmann et al., 2012; IFSAC, 2015; Osterholm, 2011; Scharff, 2012) . Likewise, the meat industry incurs significant monetary loss in millions of dollars annually due to recalls of STEC contaminated meat and meat products (Buzby & Roberts, 2009; Hoffmann et al., 2012) . Combined economic losses to public health and food agriculture are estimated at $993 million per year (Scharff, 2012) .
Antibiotic treatment of STEC infections in humans is currently not advocated in the United States, with some studies suggesting that treatment may worsen the disease by inducing the temperate phage carrying the Shiga toxin (Stx) genes to enter the lytic cycle and exacerbate toxin-related tissue damage and symptoms in patients (Melton-Celsa & O'Brien, 2014) . However, Stx production depends on the type and concentration of antibiotic used, for example, at subinhibitory levels, ciprofloxacin, trimethoprim-sulphamethoxazole can increase Stx production, but azithromycin, fosfomycin, doxycycline and gentamicin can decrease while ceftriaxone and rifampin have no effect on Stx production (McGannon et al., 2010) . A recent study found that overall antibiotic treatment is not associated with development of haemolytic uraemic syndrome (HUS, kidney failure), rather it is the type of antibiotics (e.g., β-lactam antibiotics) used within 3 days of diarrhoea which was associated with development of HUS (Smith et al., 2012) .
Antibiotics such as rifaximin, fosfomycin, azithromycin and meropenem did not stimulate release of Shiga toxin from various STEC O157 and non-O157 strains tested in in vitro studies (Kurioka et al., 1999; Ochoa, Chen, Walker, Gonzales, & Cleary, 2007) . These antibiotics have been used and are being suggested for treatment of early stages of STEC disease to prevent HUS (Bielaszewska et al., 2012; Ikeda et al., 1999; Panos et al., 2006) . STEC infections can also, in rare instances, present as urinary tract infections where use of antibiotics with supportive plasmapheresis therapy may be necessary • Presence of AR genes on mobile genetic elements enhances the chance of spreading antibiotic resistance among STEC bacteria as well as other bacteria while minimizing possible therapeutic options for human infections.
• Control strategies being explored to curtail STEC colonization of food animals could help reduce food contamination, human infections and the environmental spread of AR genes. (Nordstrom, Liu, & Price, 2013) . Considering that STEC are exposed to the same selective pressures in the host and environment as any other bacteria, use of antibiotics could increase antibiotic resistance among these foodborne pathogens. Increased antibiotic resistance in STEC, especially to promising antibiotics such as azithromycin, may render these therapeutic options ineffective in curtailing STEC during the early stages of human infection (Garcia, Silva, & Diniz, 2011; Jost, Bidet, Carrere, Mariani-Kurkdjian, & Bonacorsi, 2016) .
| PRE VALEN CE OF AR-S TEC IN ANIMAL , PRODUCE AND CLINI C AL SOURCE S
Antibiotic-resistant STEC, resistant to β-lactams, aminoglycosides, carbapenems, cephalosporins, erythromycin, phenicols, streptomycin, sulpha drugs and tetracyclines, have been recovered from livestock and humans, in the United States, Brazil, Egypt, India and Mexico (Ahmed & Shimamoto, 2015; Amézquita-López et al., 2016; Garcia et al., 2011; Mahanti et al., 2013) . While most studies have predominantly focused on the O157 serotype (Srinivasan, Nguyen, Headrick, Murinda, & Oliver, 2007; Wilkerson, Samadpour, Kirk, & Roberts, 2004) , AR has also been reported among non-O157 STEC (Table 1 ). In fact, prevalence of antibiotic resistance among human isolates has been observed to be higher in non-O157 STEC serotypes compared to O157 with sulphonamide (39.6% versus 14.4%), streptomycin (38.9% versus 17%), tetracycline (29.5% versus 9.8%) and ampicillin (23.5% versus 5.2%; Buvens, Bogaerts, Glupczynski, Lauwers, & Pierard, 2010) . Schroeder et al. (2002) ampC, qnrB, qnrS, dfrA1, aadA1, gyrA, floR, catA1, tetA, tetB, tetC, tetD, tetE, tetG, cmlA, strA, strB, sul1, sul2 Ahmed and Shimamoto (2015) Shakerian, Rahimi, and Emad (2016) and Van Meervenne et al. (2013) demonstrated that non-O157 (O26, O91, O104, O111) STEC on beef cattle hides and faecal samples were more resistant to antibiotics than O157 (Cabal et al., 2016) . These studies indicate a possible greater presence of antibiotic resistance genes among non-O157 STEC serotypes. Srinivasan et al. (2007) found that majority of the O157 (79.8%) and non-O157 STEC (91.7%) isolates obtained from human, animal and farm produce sources had one or more antimicrobial resistance gene(s) regardless of the resistance phenotype. Another study found resistance to at least one antibiotic in 40% of O157 isolated from cattle hides collected at slaughterhouses (Kramarenko et al., 2016) .
reported that the most common STEC serogroups isolated from hospital food samples (chicken and meat), in Tehran, Iran, were O26 and O157 with resistance to at least three antibiotics, including ampicillin, gentamicin and tetracycline. In another study conducted in the Eastern Cape Province of South Africa, 31.7% of O157 isolated from dairy cattle faecal samples demonstrated resistance to multiple antimicrobial agents by the disc-diffusion method and all O157 isolates were found to harbour antibiotic resistance genes, the most frequent being tetA (tetracycline resistance), strA (streptomycin resistance), bla AmpC (penicillin and cephalosporin resistance) and bla CMY-1 (cephalosporin resistance; Iweriebor, Iwu, Obi, Nwodo, & Okoh, 2015) .
Multidrug-resistant STEC have also been isolated from feedlot cattle in Canada (Rehman, Carrillo, Malouin, & Diarra, 2017) , abattoirs in Ireland (Kennedy et al., 2017) , beef and dairy products in Egypt (Ahmed & Shimamoto, 2015) , from calf in Brazil (Antonio et al., 2003) as well as in pork and chicken meat in South Korea (Park et al., 2015) .
Analysis of the clinical (human) STEC isolates collected by the
National Reference Laboratory at Ankara, Turkey, found that 62.5%
of the non-O157 STEC isolates were resistant to at least one antibiotic (Gulesen, Levent, Demir, Akgeyik, & Kuran, 2016) . A study in the United Kingdom identified resistance to ampicillin, streptomycin, sulphonamide and tetracycline among the STEC isolates recovered from patients with diarrhoea (81/430; 18%; Day et al., 2017) . In Michigan, clinical isolates (31/358, 8.6%) from patients with STEC infections were resistant to ampicillin, sulphonamides and ciprofloxacin and resistance was more common among the non-O157 (11.1%) than the O157 (5.5%) isolates (Mukherjee et al., 2017) . Few studies have reported higher prevalence of antibiotic resistance among human STEC strains compared to the bovine isolates, 47.6% versus 13%
(Cergole-Novella et al., 2006) and 12.2% versus 6.6% (Wilkerson et al., 2004) . However, the majority of studies show resistance among human isolates to be lower than in animal isolates; for instance, a study in the United States found 34% and 24% of the bovine and ground beef O157 isolates to be resistant to antibiotics, respectively, compared to 10% of human isolates (Jianghong, Shaohua, Michael, & Sam, 1998 sulfisoxazole (60% versus 30%) and streptomycin (16% versus 4%).
The reason for this difference in prevalence of AR-STEC is not known but these studies suggest that there is a prevalence of resistance among STEC isolates from both animal and human sources. (Naseer, Lobersli, Hindrum, Bruvik, & Brandal, 2017) .
| A SSO CIATI ON B E T WEEN ANTIB I OTIC RE S IS TAN CE AND VIRULEN CE IN S TEC
Multidrug resistance was observed more often among non-O157
STEC strains that carried the eae and stx1 genes (Mora et al., 2005) .
Intimin-positive, non-O157 STEC strains were found to be more resistant than intimin-negative strains to streptomycin (45.5% versus 29.5%), kanamycin (19.3% versus 4.9%) and tetracycline (35.2% versus 21.3%; Buvens et al., 2010) . In contrast, the AR-STEC isolated from patients in Michigan could only be associated with the presence of stx1 gene and those carrying the eae gene were less likely to be resistant (Mukherjee et al., 2017) . Antibiotic resistance in O157 has also been associated with specific phage types; Mora et al. (2005) found 60% of the AR-STEC O157 strains to be of the PT21/28, PT23, PT34 and PT2 phage types; and some have been found to be efficient in biofilm formation (Wang et al., 2016) . All these associations need further evaluation because other studies have not been able to establish a causal association between virulence markers and antibiotic resistance in STEC isolates (Gow & Waldner, 2009; McConnel et al., 2016) .
| EMERG ING AR-S TEC S TR AIN S
The 2011 E. coli O104:H4 German outbreak strain, which evolved from antibiotic susceptible ancestors, is a typical example of an emerging AR-STEC (Buchholz et al., 2011; Frank et al., 2011; Grad et al., 2013) . Holger et al. (2011) reported that E. coli O104:H4 evolved from an enterovirulent, enteroaggregative E. coli lineage by acquiring the genes for Stx2 toxin and antibiotic resistance. This new O104:H4 serotype was found to contain genomic islands (GIs) that conferred resistance against sulphonamides, mercury, ethidium bromide, beta lactams (GI-3), tetracyclines (GI-3 and GI-5) and tellurium (GI-1) and encoded the extended-spectrum β-lactamases (ESBL) genes (Frank et al., 2011; Grad et al., 2013) . During the 2011 outbreak, some of the patients were administered antibiotics typically used to treat E. coli O104:H4 and other superinfecting microorganisms to control invasive complications even as antibiotic therapy was being discouraged; these antibiotics included carbapenems, azithromycin and rifaximin (Bielaszewska et al., 2012; Knobloch et al., 2013; Muniesa, Hammerl, Hertwig, Appel, & Brussow, 2012) . Retrospective analysis showed that these antibiotics did not induce Stx production and may have contributed to a favourable prognosis in the treated patients (Bielaszewska et al., 2012; Knobloch et al., 2013; Muniesa et al., 2012 (Soysal et al., 2016) .
| ACQU IS ITI ON AND TR AN S MISS I ON OF ANTIB I OTI C RE S IS TAN CE IN AR-S TEC
Like other bacteria, STEC acquire resistance to antibiotics either through intrinsic or/and acquired mechanisms (Table 2) . Intrinsic mechanisms include reduced cell wall permeability to antibiotics, removal of antibiotics with efflux pumps, enzymatic degradation/ modification of antibiotics or modification of antibiotic target sites (Blair, Webber, Baylay, Ogbolu, & Piddock, 2015) . Acquired mechanisms include horizontal gene transfer (HGT) via transduction, transformation and/or conjugation; genes maybe acquired either from the environment or other bacteria (von Wintersdorff et al., 2016) .
Mobile genetic elements such as plasmids with transposon-and integron-encoded antibiotic resistance genes play a significant role in HGT (Table 2) ; such transfer has been observed between closely related and phylogenetically distant bacteria suggesting a broad host range for these plasmids (Bennett, 2008; Carattoli, 2009) .
Pathogenic E. coli including STEC carry plasmids with genes encoding for resistance to antibiotics and heavy metals (Losada et al., 2016 were found to carry Class 1 integrons with antibiotic resistance genes embedded on plasmids (Kennedy et al., 2017) . The presence of these mobile genetic elements (plasmids, integrons) in STEC may contribute towards the acquisition/dissemination of antibiotic resistance genes among these human pathogens.
Integrons are gene-capture systems that are readily mobilized on transposons and plasmids, and they play an important role in dissemination of antimicrobial resistance genes (reviewed in Mazel, 2006; Colello, Etcheverria, Conza, Gutkind, & Padola, 2015) . Integrons and antibiotic resistance gene cassettes were first reported in STEC by Zhao et al. (2001) and have since been found in several O157 as well as non-O157 isolates (Ahmed & Shimamoto, 2015; Colello et al., 2015; Singh et al., 2005; Vali et al., 2007) . Plasmids in STEC often harbour antibiotic resistance gene cassettes on integrons (Colello et al., 2015; Singh et al., 2005; Van Meervenne et al., 2013; Zhao et al., 2001) , and integron-positive strains have been found to be significantly more resistant to antibiotics compared to integron-negative strains (Van Meervenne et al., 2013) . These integron-associated AR genes, such as aadA (aminoglycoside resistance), drfA1/dfrXII (trimethoprim resistance), sul1/sat1 (sulphonamides) and bla (against β-lactamase), can be transferred to other bacteria via plasmid conjugation (Cergole-Novella, Pignatari, Castanheira, & Guth, 2011; Kruger et al., 2015; Li, Wang, & Li, 2011; Maidhof et al., 2002; Nagachinta & Chen, 2008; Zhao et al., 2001) . Class 1 integrons that contain a higher number of resistance gene cassettes than Class 2 integrons and confer better conjugation efficiency in bacteria harbouring them are found more often in STEC, as in other Gram-negative bacteria (Ahmed & Shimamoto, 2015; Colello et al., 2015; Gillings et al., 2008; Nagachinta & Chen, 2009; Vali et al., 2007) . Even when Class 1 integrons were identified only from 16% of STEC isolates analysed, 95% of these encoded for multidrug resistance (Singh et al., 2005) . Scott et al. (2009) detected β-lactamase and Class 1 integronassociated genes in MDR-STEC isolates recovered from cattle faeces and soil. In another study, overall prevalence of Class 1 integrons was observed at 45% and these could be associated with 88.9% of multidrug resistance among STEC isolated .
The transfer of antibiotic resistance genes among bacteria, through plasmids and plasmid embedded Class 1 integrons, when cultured in bovine faeces, storm water or rumen fluid, has been reported, suggesting that gene transfer can occur in various environmental settings (Cergole-Novella et al., 2011; Colello et al., 2015) . STEC persist at the recto-anal junction (RAJ) of cattle GIT and survive in manure for several months (Kudva, 2012; Kudva & Dean-Nystrom, 2011; Naylor et al., 2003) . STEC also possess a plastic genome as evidenced by the step-wise evolution (loss and gain of certain genetic materials) of pathogenic O157 from a non-toxigenic E. coli O55:H7 serotype (Wick, Qi, Lacher, & Whittam, 2005) and the emergence of new AR-STEC genotypes (Frank et al., 2011; Soysal et al., 2016) . Given the ability of STEC to persist over an extended period of time, to assimilate foreign DNA and that HGT can occur in STEC as in other bacteria (Ahmed & Shimamoto, 2015; von Wintersdorff et al., 2016) , there is a possibility that STEC may acquire antibiotic resistance genes during its persistence in the bovine gut or in manure in the environment. Of course, movement of humans, animals or food products further ensures physical dissemination of organisms, including AR-STEC, across geographical locations (Cantas et al., 2013; Day et al., 2017; Marshall & Levy, 2011) .
| CONTROL S TR ATEG IE S TARG E TING S TEC C AN AL SO MITI G ATE AR-S TEC
Intervention strategies, such as good hygiene practices by food producers and consumers alike, coupled with prudent use of antibiotics, could reduce pathogen burden in the food chain and prevent dissemination of antibiotic resistance (Livermore, 2009) 
| Standard farm/feedlot hygiene practices and carcass-hide treatments
In order to achieve the maximum reduction in cross-contamination and spread of AR-STEC on animal farms, the basic recommended principles of cattle management like sanitary housing, clean water, feed, and bedding, pest control, and environment biosecurity minimizing co-mingling of wildlife and herds from different farms have to be enforced (FSIS & USDA, 2014) . Chemicals including lactic acid, butyric acid, caprylic acid, calcium sulphate, sodium benzoate, chlorine dioxide and ozone (FDA approved) that cause 3-5 log reduction in O157 can be used to disinfect drinking water (Zhao et al., 2006) . In addition, animal hides that often get contaminated with faecal matter during transport may be washed with hot water and 
| Reduction of STEC colonization by diet alteration, probiotics and feed additives
Diets rich in phenolic acids (from forage plants), protein and digestible energy (like corn and pelleted alfalfa) can decrease shedding of pathogenic bacteria including O157 (Kudva, Hunt, Williams, Nance, & Hovde, 1997; Wells, Berry, & Varel, 2005) . Likewise, feed containing grains with lower ruminal starch degradation and higher hindgut fermentation have been associated with lower prevalence of O157 in cattle (Berg et al., 2004) . Cattle shed significantly lower numbers of O157 with a dry-rolled corn and a forage diet compared to a steam-flaked corn or a grain-based diet (Jacob, Paddock, Renter, Lechtenberg, & Nagaraja, 2010) . Switching cattle from a grain-based diet to a fibre-rich hay diet reduces the colonization of O157 through competitive exclusion by the gut microbiota, which is favoured by a high-fibre diet and less acidic pH (FSIS & USDA, 2014) . Studies have shown that seaweed, Tasco-14, in feed reduces faecal and hide prevalence of O157 in cattle (Braden, Blanton, Allen, Pond, & Miller, 2004; FSIS & USDA, 2014) . Similarly, orange peel and citrus pellets (a 50/50 mixture) at levels up to 10% dry matter (DM) were found to reduce experimentally inoculated populations of O157 in cattle (Braden et al., 2004) .
Probiotic preparations contain microorganisms that are beneficial to the host and have a preventative activity against STEC infections (reviewed in Rahal, Fadlallah, Nassar, Kazzi, & Matar, 2015) . The inoculation of animals with a probiotic prior to an experimental STEC infection has demonstrated preventative capabilities (Reissbrodt et al., 2009 (Rigobelo, Karapetkov, Maesta, Avila, & McIntosh, 2015) . These lactic acid bacteria have also been reported to reduce faecal shedding of O157 in cattle (Brashears, Jaroni, & Trimble, 2003) . Non-pathogenic E. coli that produce antimicrobial proteins, namely colicins (like colicin E7), can also reduce the overall bovine GIT colonization, and thereby faecal shedding of O157, when included in feed (Schamberger, Phillips, Jacobs, & Diez-Gonzalez, 2004 ).
Chitin is one of the most abundant polymers on earth, and its de-acetylated product known as chitosan is a "Generally Recognized as Safe (GRAS)" ingredient for use in foods, as declared by the FDA (FDA, 2013) . Chitosan microparticles (CM) are derived from chitosan by cross-linking and have several pharmaceutical applications including drug delivery and wound healing (Illum, 1998) . CM-supplemented feed was found to significantly reduce O157 carriage and shedding in experimentally challenged cattle (2 versus 14 days following oral inoculation of E. coli O157; Jeong et al., 2011) . Antimicrobial activity of CM against extended-spectrum β-lactamase (ESBL)-producing E. coli, Klebsiella pneumoniae, MRSA and vancomycin-resistant Enterococci, has been demonstrated in in vitro assays, as also its ability to reduce O157 shedding in cattle without inducing Shiga toxin encoding bacteriophages, which support their potential to be used as alternatives to antibiotics (Ma et al., 2016) . Varela et al., 2013) . In addition, in a simulation model, a 50% and 80% drop in the frequency of shedding in cattle and human cases, respectively, was achieved by eliminating just the 12% highest shedding animals (Matthews et al., 2013) .
| Vaccines
In a study comparing cattle vaccinated with O157 T3SS proteins to non-vaccinated/placebo cattle, a reduction in the numbers of O157 shed in faeces (6.25 CFU/g faeces in vaccinated cattle versus 81.25 CFU/g faeces in placebo group), the number of animals that shed this bacteria (62.5% versus 87.5%) and the duration of O157
shedding (<2 versus >4 consecutive days) were observed (Potter et al., 2004) . However, recently, the vaccine was reported to be ineffective against Stx2 carrying O157 strains (Stanford, Hannon, Booker, & Jim, 2014) . The three-dose SRP cattle vaccine regimen was 85% effective in reducing O157 by an average of 1.7 log 10 units in faeces (Thomson et al., 2009) . In a commercial feedlot, the SRP vaccine demonstrated 53% efficacy in reducing O157 prevalence and 73% efficacy in reducing prevalence of high shedders among cattle (Cull et al., 2012) . Overall, these studies support cattle vaccination can effectively reduce STEC shedding (Varela et al., 2013) and researchers are experimentally evaluating new formulations that may improve efficacy or provide alternatives to existing vaccines (Martorelli et al, 2017; Saeedi, Yazdanparast, & Behzadi, 2017; Schmidt et al., 2018) .
However, farmers in the United States and Canada have shown little interest in vaccinating their cattle against bacteria that cause no disease in these animals without any incentives or regulatory mandates (Matthews et al., 2013; Smith, 2014) .
| Bacteriophages
Lytic bacteriophages have been used as biocontrol agents against STEC in beef, lettuce, milk and laboratory cultures of O157 (Carter et al., 2012; Kudva et al., 1999; Tomat, Mercanti, Balague, & Quiberoni, 2013) . In addition, naturally phage-infected ruminants have been shown to be more resistant to O157 colonization (Stanford et al., 2010) . A mixture of three lytic phages (KH1, KH4 and KH5) were shown to specifically target O157 (Kudva et al., 1999) . Likewise, coliphages DT1 and DT6 that target E. coli have been shown to effectively reduce STEC counts when administered individually or together in a mix (Tomat et al., 2013) . Since bacteriophages effectively reduce initial bacterial contamination (Carter et al., 2012) biocontrol potential as it lacks known virulence and lysogenic genes (Amarillas et al., 2016) . These studies suggest lytic bacteriophages can be used to target STEC without spreading antibiotic resistance.
| Judicious use of antibiotics
Antibiotics have been used for growth promotion in farm animals since the 1940s (Slocombe & Sutherland, 1973) and global antimicrobial usage for livestock production is projected to increase by 67% by the year 2030 (Van Boeckel et al., 2015) . Increased human consumption has led to a shift towards intensified animal farming resulting in increased antibiotic usage for health maintenance and
production. This in turn may have contributed to the selection of antibiotic-resistant populations in the animal GIT and their subsequent spread to the environment via faeces (Checkley, Campbell, ChirinoTrejo, Janzen, & Waldner, 2010; Van Boeckel et al., 2015) . High prevalence of antibiotic resistance genes among zoonotic, foodborne pathogens including STEC is of public health concern (Laura et al., 2015; Neil, 2016) as it poses clinical management challenges.
Judicious use of antibiotics could delay or prevent the emergence of new resistance and reduce treatment costs against AR pathogens (Bush et al., 2011) . Antibiotic alternatives such as, ionophores, may be used to promote animal growth (FDA, 2015) . In addition, medi- antibiotic approaches for the prevention of infections could help reduce prevalence of AR bacteria (Laura et al., 2015; Neil, 2016; WHO, 2014 WHO, , 2016 .
| CON CLUS ION
Shiga toxin-producing Escherichia coli are not only detrimental to human health but cause severe economic losses to food industry due to recalls of contaminated meat and produce. Presence of AR genes on mobile genetic elements in STEC strains, as discussed in this review, further necessitates understanding of resistance profiles among commonly isolated STEC serotypes. This is especially relevant when it comes to establishing new antibiotic-based therapies for early-stage STEC infections in humans that may help prevent serious secondary sequelae. While it is not uncommon for pathogens to harbour AR genes even in the absence of selection pressures, prudent use of antibiotics could lower the risk of a bacterium evolving into a multidrug-resistant strain or developing new resistance. At the same time, adapting pre-harvest strategies that minimize or curtail STEC/AR-STEC shedding by reservoirs could help reduce food contamination, human infections, as well as the environmental spread of AR genes.
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